Lymphoscintigraphy and intraoperative lymphatic mapping of sentinel lymph nodes in melanoma patients

Journal of Nuclear Medicine Technology

Volumn 27, Issue 4, 1999, Pages 309-317

  Williams, Bonnie S ^a   Hinkle, George H ^b   Douthit, Renita A ^b   Fry, Jane P ^b   Pozderac, Rodney V ^b   Olsen, John O ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NONE

Author keywords

Gamma detecting probe; Intraoperative lymphatic mapping; Lymphoscintigraphy; Melanoma; Oncology; Sentinel lymph node

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; PATIENT MONITORING; REVIEW;

HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; RADIOPHARMACEUTICALS; ROSANILINE DYES; SKIN NEOPLASMS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0033373957     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. www cancer.org/statistics/off99/selectedcancers.html. Atlanta, GA: American Cancer Society; 1999.
2. www.seer.irns.nci.nih.gov. Bethesda, MD. National Cancer Institute; 1999.
3. Morton DL, Wen DR, Cochran AJ Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am. 1992;1:247-259.
4. Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol. 1993;2:303-308.
5. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol. 1993;2:137-143.
6. Morton DL. Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399
7. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654-658.
8. Meyer CM, Lecklitner ML, Logic JR, et al. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma-Radiology. 1979, 131:205-209.
9. Munz DL, Altmeyer P, Sessler MJ, et al. Axillary lymph node groups - the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. Lymphology. 198215: 143-147.
10. Reintgen DS, Sullivan D, Coleman E, et al. Lymphoscintigraphy for malignant melanoma Surgical considerations. Am Surg. 1983;49:672-678.
11. Kramer EL, Sanger JJ, Colomb F, et al. The impact of intradermal lymphoscintigraphy on surgical management of clinical Stage I truncal malignant melanoma. J Dermatol Surg Oncol. 1987:13:508-515.
12. Eberbach MA, Wahl RL. Argenta LC, et al. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. Surgery. 1987:102:433-442.
13. Berman CG. Norman J, Cruse CW, et al. Lymphoscintigraphy in malignant melanoma. Ann Plastic Surg. 1992: 8:29-32.
14. Norman J, Cruse CW, Espinosa C. et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant mclanoma. Am J Surg. 1991; 162:432-437.
15. Uren RF. Howman-Giles RB. Shaw HM, et al. Lymphoscintigraphy in high-risk melanoma of the trunk predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993;34: 1435-1440.
16. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996:223:217-224.
17. Godellas CV, Berman CG, Lyman G, et al The identification and mapping of melanoma regional nodal metastases. minimally invasive surgery for the diagnosis of nodal metastases. Am Surgeon. 1995;61:97-101
18. Wells KE, Cruse CW, Daniels S, et al. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 1994;93 757-761.
19. Kapteijn BA, Nieweg OE, Muller SH. et al. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med. 1997;38:362-366.
20. Bostick P, Essner R, Saraniou T. et al Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg. 1997;174:536-539.
21. Alazraki NP, Eshima D. Eshima LA. et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med. 1997;27:55-67.
22. Seeley RR, Stephens TD, Tate P. Anatomy & Physiology. 2nd ed. St. Louis, MO: Mosby Year-Book: 1992:670.
23. Kramer EL. Lymphoscintigraphy: radiopharmaceutical selection and methods. Int J Radiat Applications and Instrumentation-Part B. Nucl Med Biol. 1990;17:57-63.
24. Hung JC. Wiseman GA, Wahner HW, et al. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med. 1995;36:1895-1901
25. Glass EC. Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-1190.
26. Goldfarb LR, Alazraki NP, Eshima D, et al. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid. Radiology. 1998;208:505-509.
27. Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6:1238-1240.